» Articles » PMID: 34508630

Primary Care Heart Failure Service Identifies a Missed Cohort of Heart Failure Patients with Reduced Ejection Fraction

Overview
Journal Eur Heart J
Date 2021 Sep 11
PMID 34508630
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: We explored whether a missed cohort of patients in the community with heart failure (HF) and left ventricular systolic dysfunction (LVSD) could be identified and receive treatment optimization through a primary care heart failure (PCHF) service.

Methods And Results: PCHF is a partnership between Inspira Health, National Health Service Cardiologists and Medtronic. The PCHF service uses retrospective clinical audit to identify patients requiring a prospective face-to-face consultation with a consultant cardiologist for clinical review of their HF management within primary care. The service is delivered via five phases: (i) system interrogation of general practitioner (GP) systems; (ii) clinical audit of medical records; (iii) patient invitation; (iv) consultant reviews; and (v) follow-up. A total of 78 GP practices (864 194 population) have participated. In total, 19 393 patients' records were audited. HF register was 9668 (prevalence 1.1%) with 6162 patients coded with LVSD (prevalence 0.7%). HF case finder identified 9725 additional patients to be audited of whom 2916 patients required LVSD codes adding to the patient medical record (47% increase in LVSD). Prevalence of HF with LVSD increased from 0.7% to 1.05%. A total of 662 patients were invited for consultant cardiologist review at their local GP practice. The service found that within primary care, 27% of HF patients identified for a cardiologist consultation were eligible for complex device therapy, 45% required medicines optimization, and 47% of patients audited required diagnosis codes adding to their GP record.

Conclusion: A PCHF service can identify a missed cohort of patients with HF and LVSD, enabling the optimization of prognostic medication and an increase in device prescription.

Citing Articles

Point-of-care AI-enhanced novice echocardiography for screening heart failure (PANES-HF).

Huang W, Koh T, Tromp J, Chandramouli C, Ewe S, Ng C Sci Rep. 2024; 14(1):13503.

PMID: 38866831 PMC: 11169397. DOI: 10.1038/s41598-024-62467-4.


A multicomponent complex intervention for supportive follow-up of persons with chronic heart failure: a randomized controlled pilot study (the UTILE project).

Schafer-Keller P, Graf D, Denhaerynck K, Santos G, Girard J, Verga M Pilot Feasibility Stud. 2023; 9(1):106.

PMID: 37370176 PMC: 10294419. DOI: 10.1186/s40814-023-01338-7.


Optimizing outcomes in heart failure: 2022 and beyond.

Jankowska E, Andersson T, Kaiser-Albers C, Bozkurt B, Chioncel O, Coats A ESC Heart Fail. 2023; 10(4):2159-2169.

PMID: 37060168 PMC: 10375115. DOI: 10.1002/ehf2.14363.


Survival and health economic outcomes in heart failure diagnosed at hospital admission versus community settings: a propensity-matched analysis.

Bachtiger P, Kelshiker M, Petri C, Gandhi M, Shah M, Kamalati T BMJ Health Care Inform. 2023; 30(1).

PMID: 36921978 PMC: 10030479. DOI: 10.1136/bmjhci-2022-100718.


Mixed-methods evaluation of a multifaceted heart failure intervention in general practice: the OSCAR-HF pilot study.

Smeets M, Raat W, Aertgeerts B, Penders J, Vercammen J, Droogne W ESC Heart Fail. 2022; 10(2):907-916.

PMID: 36461750 PMC: 10053264. DOI: 10.1002/ehf2.14251.

References
1.
Fuat A, Hungin A, Murphy J . Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ. 2003; 326(7382):196. PMC: 140276. DOI: 10.1136/bmj.326.7382.196. View

2.
Ottenberg A, Mueller P, Topazian R, Kaufman S, Swetz K . "It's not broke, so let's not try to fix it": why patients decline a cardiovascular implantable electronic device. Pacing Clin Electrophysiol. 2014; 37(10):1306-14. PMC: 4393709. DOI: 10.1111/pace.12433. View

3.
Seferovic P, Fragasso G, Petrie M, Mullens W, Ferrari R, Thum T . Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure. Eur J Heart Fail. 2020; 22(11):1984-1986. DOI: 10.1002/ejhf.2026. View

4.
Hawkins N, Jhund P, McMurray J, Capewell S . Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail. 2012; 14(2):138-46. DOI: 10.1093/eurjhf/hfr168. View

5.
Grayson A, Garnett F, Davies M, Connor N, Hughes C, Cooper J . A consultant-led anticoagulation review of all patients in one clinical commissioning group to prevent atrial fibrillation related stroke. Int J Clin Pract. 2019; 74(4):e13465. DOI: 10.1111/ijcp.13465. View